Jason Mast (@Jasonmmast) | Siddz Nitter

170 Photos and videos

Jason Mast retweeted

Brian Reid @brianreid

11h

This feels really, really important, no?

Jason Mast @Jasonmmast

12h

This year, a loosely regulated clinical trial system in China gained global attention after the deaths of three patients. Now, a rare disease advocate says one of the only paths to creating drugs for desperate kids is being closed off. statnews.com/2026/11/05/chin…

1

4

384

Jason Mast @Jasonmmast

11h

RT @rickberke: Sharp reporting by @isabellacueto

2

27

Jason Mast @Jasonmmast

12h

Revolution Medicines’ pancreatic cancer drug has stunning commercial debut statnews.com/2026/11/05/raso… via @statnews

Revolution's pancreatic cancer drug has stunning commercial debut

Rasonque, Revolution Medicines' new pancreatic cancer drug, is off to one of the best oncology drug launches in history.

1

7

1,387

Jason Mast @Jasonmmast

12h

This year, a loosely regulated clinical trial system in China gained global attention after the deaths of three patients. Now, a rare disease advocate says one of the only paths to creating drugs for desperate kids is being closed off. statnews.com/2026/11/05/chin…

In China, a flood of controversial clinical trials slows to a trickle

Following patient deaths, China restricts investigator-initiated biotech trials, leaving rare disease families and US investors facing an uncertain future.

6

11

1,166

Jason Mast retweeted

🌸 Chelsea Cirruzzo @ChelseaCirruzzo

Nov 4

Good morning! I have a round-up of the ⭐️ winners & losers ⭐️ of last night's big Democrat blowout. Winners? Democratic doctors & Medicare for All. Losers? MAHA and potentially RFK Jr, who could face big questions in the Dem-controlled Congress. statnews.com/2026/11/04/midt…

Five midterm winners and losers: MAHA mowed down, Dem docs scrub in, Medicare for All returns

Democratic doctors were among the winners in the midterm elections, while the MAHA movement and President Trump's health agenda were losers.

4

2

809

Jason Mast @Jasonmmast

13h

In China, a flood of controversial clinical trials slows to a trickle Rare disease families have been left in limbo statnews.com/2026/11/05/chin…

In China, a flood of controversial clinical trials slows to a trickle

Following patient deaths, China restricts investigator-initiated biotech trials, leaving rare disease families and US investors facing an uncertain future.

1

4

6

659

Jason Mast retweeted

Adam Feuerstein ✡️

@adamfeuerstein

14h

In China, a flood of controversial clinical trials slows to a trickle statnews.com/2026/11/05/chin… via @Jasonmmast

In China, a flood of controversial clinical trials slows to a trickle

Following patient deaths, China restricts investigator-initiated biotech trials, leaving rare disease families and US investors facing an uncertain future.

3

18

7,845

Jason Mast retweeted

🌸 Chelsea Cirruzzo @ChelseaCirruzzo

Nov 4

My coworker @AnilOza16 by the way has a great profile on everything health care senator-elect Abdul El-Sayed wants to achieve. First and foremost: Reviving Medicare for All. statnews.com/2026/10/28/abdu…

Senate candidate El-Sayed wants to 'grill' RFK Jr., calls him the 'most incompetent HHS secretary...

Abdul El-Sayed has made headlines for his progressive politics and stance on Israel. But some supporters consider his public health background critical.

3

4

607

Jason Mast retweeted

Adam Feuerstein ✡️

@adamfeuerstein

14h

Revolution’s $RVMD pancreatic cancer drug has stunning commercial debut It might be too early to call Rasonque the best cancer drug launch in history, but it’s certainly close, and investors are now re-evaluating their forecasts for what lies ahead. statnews.com/2026/11/05/raso…

Revolution's pancreatic cancer drug has stunning commercial debut

Rasonque, Revolution Medicines' new pancreatic cancer drug, is off to one of the best oncology drug launches in history.

5

8

81

11,914

Jason Mast retweeted

Isa Cueto @isabellacueto

Nov 4

Where does MAHA go after a searing midterm rebuke? Here are three possibilities: statnews.com/2026/11/04/maha…

Where does MAHA go from here? Three possible futures

Republican losses leave Robert F. Kennedy Jr.’s MAHA movement with three possible futures.

5

7

9

16,655

Jason Mast retweeted

Margaret Manto

@MargaretManto

Nov 4

🚨wonk alert🚨 I wrote about how the Democratic landslide could have serious implications for the FDA's funding structure -- by empowering Bernie Sanders statnews.com/2026/11/04/bern…

Pharma critic Bernie Sanders is set to hold major sway over FDA funding bill

Sanders could use his role in crafting the bill to push for reforms.

1

15

45

16,262

Jason Mast retweeted

Daniel Payne @_daniel_payne

Nov 4

Plenty of frustration from some MAHA leaders tonight. The midterms are a first — and crucial — political moment for the movement: statnews.com/2026/10/09/maha…

Will MAHA survive the midterms?

As the midterm elections draw near, the MAHA movement is nearly invisible on the campaign trail and struggling to find a financial or messaging foothold in key races.

5

6

1,787

Jason Mast retweeted

🌸 Chelsea Cirruzzo @ChelseaCirruzzo

Nov 3

🗳️ IT'S ELECTION DAY 🗳️ and my colleagues at @statnews have everything you need to know about health care in the midterms, starting with @_daniel_payne on the biggest ways votes cast today could change how you receive care: statnews.com/2026/10/31/midt…

What are the health stakes of the midterms? Policymakers, lobbyists, and experts weigh in

No matter what happens on Election Day, the midterms will have sweeping implications for American health care. More than two dozen experts on what could come next.

1

13

15

2,937

Jason Mast retweeted

Matthew Herper

@matthewherper

Oct 27

I went on NPR's "Here and Now" to talk about the Merck-Moderna cancer vaccines: What the data mean, what they don't mean, and what people should take away. Have a listen! wbur.org/hereandnow/2026/10/…

Moderna and Merck's mRNA vaccine reduces melanoma recurrence by 42%

Melanoma is one of the deadliest skin cancers, and the results of the study have many in the field wondering if this therapy can be applied to other deadly cancers.

4

9

2,380

Jason Mast @Jasonmmast

Oct 27

Pennsylvania Dutch country, tired of waiting for biopharma, builds drug company of its own statnews.com/2026/10/27/gene…

Pennsylvania Dutch country, tired of waiting for biopharma, builds drug company of its own

A small community tests if it can solve a crisis no one else could, for the simple reason that they have no other choice.

1

6

11

1,894

Jason Mast retweeted

Adam Feuerstein ✡️

@adamfeuerstein

Oct 27

There is no better reporter anywhere covering rare diseases than STAT's @Jasonmmast. Today, another masterpiece: Pennsylvania Dutch country, tired of waiting for biopharma, builds drug company of its own statnews.com/2026/10/27/gene…

Pennsylvania Dutch country, tired of waiting for biopharma, builds drug company of its own

A small community tests if it can solve a crisis no one else could, for the simple reason that they have no other choice.

6

10

61

12,936

Jason Mast @Jasonmmast

Oct 27

Moderna CEO on what’s next after success in cancer vaccine statnews.com/2026/10/26/mode… via @statnews

Moderna CEO on what’s next after success in cancer vaccine

Moderna's CEO Stéphane Bancel on what's next after the recent success of a cancer vaccine, and how that impacts the company's business strategy.

4

861

Jason Mast retweeted

Matthew Herper

@matthewherper

Oct 23

Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer statnews.com/2026/10/23/esmo… via @statnews

Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer

An experimental drug combination led to tumor responses in 82% of patients with a certain type of advanced pancreatic cancer, Tango Therapeutics reported.

6

8

51

5,177

Jason Mast retweeted

Max Bayer @maxonwifi

Oct 22

The COINS rules are out and they are EXTREMELY broad on pharma. The focus had been whether certain kinds of China biotech transactions would be limited. As currently written, the rule limits deals for any pharma compounds. Public comments til Dec. 7. endpoints.news/treasury-prop…

Treasury proposal would sharply limit US investments in much of China biotech

Treasury’s draft outbound investment rules would sharply limit US deals for Chinese drug and biotech assets, opening a 45-day comment period.

3

8

21

5,084

Jason Mast retweeted

Adam Feuerstein ✡️

@adamfeuerstein

Oct 21

Housekeeping note: I'm flying to Madrid tonight to cover #ESMO26, joined by my colleague @DrewQJoseph We'll have stories + our ESMO pop-up newsletter. If you want to receive the latter (it's free) you can sign up here: statnews.com/signup/esmo-30-…

ESMO in 30 Seconds

Your guide to this year's ESMO Congress

3

6

29

8,007